Antimicrobial and Biological Methods to Control Liver Abscesses

Miles E Theurer; Raghavendra G Amachawadi

doi:10.1016/j.cvfa.2022.07.001

Antimicrobial and Biological Methods to Control Liver Abscesses

Vet Clin North Am Food Anim Pract. 2022 Nov;38(3):383-394. doi: 10.1016/j.cvfa.2022.07.001.

Authors

Miles E Theurer¹, Raghavendra G Amachawadi²

Affiliations

¹ Veterinary Research and Consulting Services, KS, USA. Electronic address: miles@vrcsllc.com.
² Department of Clinical Sciences, Kansas State University, Mosier Hall Q 221, 1800 Denison Avenue, Manhattan, KS 66506, USA.

PMID: 36243460
DOI: 10.1016/j.cvfa.2022.07.001

Abstract

Antimicrobial products are approved for the control of liver abscesses with varying amounts of data. When compared to negative controls, tylosin has the most data to support a reduction in total (risk ratio 0.34) and severe A+ (risk ratio 0.31) liver abscesses. Due to the reduction in the use of antimicrobials, vaccination to control liver abscess prevalence is intriguing. However, available vaccines do not appear to be effective in controlling the prevalence of liver abscesses, especially when the disease prevalence is high.

Keywords: Efficacy; Label; Tylosin; Vaccine.

Publication types

Review

MeSH terms

Animals
Anti-Bacterial Agents / therapeutic use
Cattle
Cattle Diseases* / prevention & control
Liver Abscess* / drug therapy
Liver Abscess* / epidemiology
Liver Abscess* / veterinary
Tylosin / therapeutic use

Substances

Anti-Bacterial Agents
Tylosin